| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,258 |
5,564 |
$407K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,923 |
2,569 |
$309K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
2,528 |
2,479 |
$199K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,173 |
1,162 |
$124K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
804 |
794 |
$83K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
842 |
770 |
$81K |
| 90461 |
|
1,330 |
1,306 |
$54K |
| 90670 |
|
256 |
251 |
$50K |
| 90700 |
|
836 |
828 |
$21K |
| 99177 |
|
1,049 |
1,043 |
$19K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
171 |
166 |
$19K |
| 90671 |
|
78 |
77 |
$19K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
343 |
319 |
$16K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
330 |
309 |
$16K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
497 |
494 |
$14K |
| 90713 |
|
370 |
368 |
$13K |
| 90686 |
|
690 |
682 |
$13K |
| 96127 |
|
1,229 |
1,209 |
$9K |
| 90674 |
|
301 |
299 |
$9K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,098 |
1,071 |
$8K |
| 92558 |
|
635 |
627 |
$7K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
467 |
319 |
$7K |
| 92551 |
|
446 |
441 |
$6K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
543 |
507 |
$6K |
| 90648 |
|
386 |
383 |
$4K |
| 90661 |
|
105 |
105 |
$4K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
285 |
284 |
$3K |
| 90734 |
|
25 |
24 |
$3K |
| 90688 |
|
133 |
133 |
$3K |
| 90680 |
|
27 |
27 |
$2K |
| 87070 |
|
275 |
256 |
$2K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
58 |
52 |
$1K |
| 81002 |
|
470 |
434 |
$1K |
| 90685 |
|
30 |
30 |
$632.49 |
| 99173 |
|
181 |
181 |
$629.01 |
| 0072A |
|
16 |
16 |
$545.12 |
| 90633 |
|
14 |
13 |
$424.58 |
| 99051 |
|
15 |
15 |
$376.05 |
| 90744 |
|
13 |
13 |
$352.56 |
| 96161 |
|
110 |
107 |
$313.27 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
30 |
28 |
$276.82 |
| 0071A |
|
13 |
13 |
$264.29 |
| 92567 |
|
14 |
13 |
$225.36 |
| 81003 |
|
27 |
26 |
$62.10 |
| 94760 |
|
61 |
55 |
$49.50 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
612 |
487 |
$13.11 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
1,812 |
1,792 |
$0.00 |
| 91307 |
|
38 |
36 |
$0.00 |
| 99072 |
|
16 |
16 |
$0.00 |